Ä¿¹Â´ÏƼ

¾¾¾ÆÀ̹ÙÀÌ¿À´Â ¹ÏÀ½°ú ½Å·Ú¸¦ ¹ÙÅÁÀ¸·Î
±Í»çÀÇ ±¹³», ÇØ¿ÜÁøÃâÀÇ ÆÄÆ®³Ê°¡ µÇ°Ú½À´Ï´Ù.

Ä¿¹Â´ÏƼ

  • Ȩ
  • Ä¿¹Â´ÏƼ
  • ÀÚ·á½Ç

ÀÚ·á½Ç

¹øÈ£ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏÀÚ Á¶È¸¼ö
°øÁö Licence in, out , sales related °ü¸®ÀÚ 2024-07-09 114
°øÁö FDA ÄÁ¼³ÆÃ, ¹Ì±¹ ÁøÃâ ½ÃÀåÁ¶»ç, Áö¿ø µå¸³´Ï´Ù. °ü¸®ÀÚ 2023-03-27 130
°øÁö EU Regulatory MDD ¿¡¼­ MDR, IVDR Àüȯ¿¡ µû¸¥ Clinical trialÀ» Æ÷ÇÔÇÑ Áö¿ø¹× Áغñ.. °ü¸®ÀÚ 2023-03-27 106
19 Peptide Manufacturing Service °ü¸®ÀÚ 2025-04-04 17
18 Cell culture new material ,BD opportunity °ü¸®ÀÚ 2025-04-04 8
17 Sales right opportunity °ü¸®ÀÚ 2025-04-04 10
16 Relation Opportunity °ü¸®ÀÚ 2025-03-27 19
15 Investment Opportunity in a Leading Dermato-Oncology °ü¸®ÀÚ 2025-03-27 17
14 licensing, marketing opportunity °ü¸®ÀÚ 2025-03-26 24
13 Medical related added (Smart Wearable Device, digital health care,consulting ) i.. °ü¸®ÀÚ 2025-03-17 18